Agency Forms Undergoing Paperwork Reduction Act Review, 21810-21811 [E9-10938]

Download as PDF 21810 Federal Register / Vol. 74, No. 89 / Monday, May 11, 2009 / Notices Revision—National Center on Birth Defects and Developmental Disabilities (NCBDDD), Centers for Disease Control and Prevention (CDC). Background and Brief Description The National Center on Birth Defects and Developmental Disabilities at CDC promotes the health of babies, children, and adults with disabilities. As part of these efforts the Center is actively involved in addressing hearing loss (HL) among newborns and infants. HL is a common birth defect that affects approximately 12,000 infants each year and, when left undetected, can result in developmental delays. As awareness about infant HL increases, so does the demand for accurate information about rates of screening, referral, loss to follow-up, and incidence. This information is important for helping to ensure infants and children are territories. The request to complete this survey is planned to be disseminated to respondents via an e-mail, which will include a summary of the request and other relevant information. Minor changes to this survey, based on respondent feedback, are planned in order to make the survey easier to complete and further improve data quality. These changes include splitting the previously combined questions about the number of infants that died and parents refused into two separate questions, adding a question about how many infants with hearing loss are receiving only monitoring services, simplifying the table for reporting type and severity of hearing loss data, and expanding the maternal race categories in the demographic section. There are no costs to the respondents other than their time. receiving recommended screening and follow-up services, documenting the occurrence and etiology of differing degrees of HL among infants, and determining the overall impact of infant HL on future outcomes, such as cognitive development, and family dynamics. These data will also assist state Early Hearing Detection and Intervention (EHDI) programs with quality improvement activities and provide information that will be helpful in assessing the impact of federal initiatives. The public will be able to access this information via the CDC EHDI Web site (https://www.cdc.gov/ ncbddd/ehdi/data.htm). Given the lack of a standardized and readily accessible source of data, the CDC EHDI program developed a survey to be used annually that utilizes uniform definitions to collect aggregate, standardized EHDI data from states and ESTIMATED ANNUALIZED BURDEN HOURS Respondents Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) State and territory EHDI Program Coordinators .............................................. 53 1 4 212 Dated: May 5, 2009. Marilyn S. Radke, Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–10937 Filed 5–8–09; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention [30Day–09–08BL] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. 15:05 May 08, 2009 Jkt 217001 Multi-site HIV Testing in Community Mental Health Settings Serving African Americans—New—National Center for HIV, Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Nov<24>2008 Proposed Project People with severe mental illness, including those with substance use disorders, are at increased risk of infection with human immunodeficiency virus (HIV) when compared with the general population. However, not enough is known about the risk behaviors, willingness to be tested for HIV, and prevalence of HIV among persons with severe mental illness. In addition, the interrelations among diagnosis of HIV, compliance with medical care, subsequent risk behaviors, and the course of mental illness have not been well-described. Mental health clinics are an important setting for testing and promoting prevention efforts against the transmission of HIV. The objectives of this project are to (1) demonstrate improved access to HIV testing and linkage to care in participating mental health care settings and (2) describe the relationship between mental illness, HIV risk behaviors, and access to testing and PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 services, in order to inform the development of optimal prevention interventions for persons with severe mental illness. Staff at selected implementation sites will offer testing for HIV to clients and administer a brief survey to assess risk behaviors, previous access to similar testing services, and mental health symptoms. This project will collect data from clients using brief surveys administered on a voluntary basis. Collection of data will provide information on client demographics; current behaviors that may facilitate HIV transmission, including sexual and drug-use behaviors; current psychiatric symptoms, determined using brief rating scales; access and barriers to HIV testing, prevention, and treatment services; and adherence to psychiatric and medical treatment regimens. CDC is requesting approval for a 2-year clearance for data collection. Data will be collected in 6 sites which provide mental health services. The goal will be to approach 716 persons annually for participation in the study and interview a total of 600 persons. Based on the University of Pennsylvania’s prior experience working in mental health settings, it is estimated that of the 716 approached for participation in the study, the response rate will be approximately 90%. Of the 644 persons approached who agree to be E:\FR\FM\11MYN1.SGM 11MYN1 21811 Federal Register / Vol. 74, No. 89 / Monday, May 11, 2009 / Notices surveyed, it is estimated that 95% of persons will meet the eligibility criteria and 98% will be able to provide informed consent, as determined by the consent comprehension test. Therefore, the goal will be to interview a sample of 600 persons annually for two years; 300 in each of the two project areas of Baltimore and Philadelphia. The structured interview will take approximately 20 minutes to complete. Participation is voluntary. Data collection will provide important insights into the relationship between psychiatric illness and risk behaviors for HIV. There is no cost to the respondents other than their time. The total annualized burden hours are 313. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Form name Approached individual ..................................... Eligible participant ........................................... Consented participant ..................................... Eligibility Screener .......................................... Consent Questionnaire .................................. Core Questionnaire ........................................ Dated: May 5, 2009. Marilyn S. Radke, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–10938 Filed 5–8–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Institutes of Health Peer Review Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Institutes of Health Peer Review Advisory Committee. Date: June 8, 2009. Time: 8:30 a.m. to 5 p.m. Agenda: Provide technical and scientific advice and recommendations to the NIH Director, the Deputy Director for Extramural Research, and the Director of the Center for Scientific Review (CSR) on all procedures and policies related to the process of peer review by which the scientific and technical merit of NIH grant applications is assessed. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Cheryl A. Kitt, PhD, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3030, MSC 7776, Bethesda, MD 20892, 301–435– 1112, kittc@csr.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on VerDate Nov<24>2008 15:05 May 08, 2009 Jkt 217001 this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: May 04, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–10781 Filed 5–8–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel; RFA–AA–09–006— Mechanism of Alcohol-Induced Organ Damage (R01). Date: July 13–14, 2009. Time: 8 a.m. to 5 p.m. PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 Number of responses per respondent 644 612 600 Average burden per response (in hours) 1 1 1 1/60 10/60 20/60 Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Philippe Marmillot, PhD, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, 5635 Fishers Lane, Rm 2017, Bethesda, MD 20892, 301–443–2861, marmillotp@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.891, Alcohol Research Center Grants, National Institutes of Health, HHS) Dated: May 4, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–10786 Filed 5–8–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\11MYN1.SGM 11MYN1

Agencies

[Federal Register Volume 74, Number 89 (Monday, May 11, 2009)]
[Notices]
[Pages 21810-21811]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-10938]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-09-08BL]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.

Proposed Project

    Multi-site HIV Testing in Community Mental Health Settings Serving 
African Americans--New--National Center for HIV, Viral Hepatitis, STD 
and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    People with severe mental illness, including those with substance 
use disorders, are at increased risk of infection with human 
immunodeficiency virus (HIV) when compared with the general population. 
However, not enough is known about the risk behaviors, willingness to 
be tested for HIV, and prevalence of HIV among persons with severe 
mental illness. In addition, the interrelations among diagnosis of HIV, 
compliance with medical care, subsequent risk behaviors, and the course 
of mental illness have not been well-described. Mental health clinics 
are an important setting for testing and promoting prevention efforts 
against the transmission of HIV.
    The objectives of this project are to (1) demonstrate improved 
access to HIV testing and linkage to care in participating mental 
health care settings and (2) describe the relationship between mental 
illness, HIV risk behaviors, and access to testing and services, in 
order to inform the development of optimal prevention interventions for 
persons with severe mental illness. Staff at selected implementation 
sites will offer testing for HIV to clients and administer a brief 
survey to assess risk behaviors, previous access to similar testing 
services, and mental health symptoms. This project will collect data 
from clients using brief surveys administered on a voluntary basis. 
Collection of data will provide information on client demographics; 
current behaviors that may facilitate HIV transmission, including 
sexual and drug-use behaviors; current psychiatric symptoms, determined 
using brief rating scales; access and barriers to HIV testing, 
prevention, and treatment services; and adherence to psychiatric and 
medical treatment regimens. CDC is requesting approval for a 2-year 
clearance for data collection. Data will be collected in 6 sites which 
provide mental health services.
    The goal will be to approach 716 persons annually for participation 
in the study and interview a total of 600 persons. Based on the 
University of Pennsylvania's prior experience working in mental health 
settings, it is estimated that of the 716 approached for participation 
in the study, the response rate will be approximately 90%. Of the 644 
persons approached who agree to be

[[Page 21811]]

surveyed, it is estimated that 95% of persons will meet the eligibility 
criteria and 98% will be able to provide informed consent, as 
determined by the consent comprehension test. Therefore, the goal will 
be to interview a sample of 600 persons annually for two years; 300 in 
each of the two project areas of Baltimore and Philadelphia. The 
structured interview will take approximately 20 minutes to complete. 
Participation is voluntary. Data collection will provide important 
insights into the relationship between psychiatric illness and risk 
behaviors for HIV.
    There is no cost to the respondents other than their time. The 
total annualized burden hours are 313.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondent                    Form name           respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Approached individual.................  Eligibility Screener....             644               1            1/60
Eligible participant..................  Consent Questionnaire...             612               1           10/60
Consented participant.................  Core Questionnaire......             600               1           20/60
----------------------------------------------------------------------------------------------------------------


    Dated: May 5, 2009.
Marilyn S. Radke,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E9-10938 Filed 5-8-09; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.